BACKGROUND/AIMS: Brush cytology during ERCP can provide a pathologic diagnosis in malignant biliary obstruction. K-ras and p53 mutations are commonly found in biliary and pancreatic cancers. We evaluated the diagnostic yield of brush cytology and the changes obtained by adding p53 and K-ras staining. METHODS: One hundred and forty patients with biliary obstruction who underwent ERCP with brush cytology during a 7-year period were included. The sensitivity and specificity of brush cytology only and with the addition of p53 and K-ras staining were obtained. RESULTS: Malignant biliary obstruction was confirmed in 119 patients. The sensitivity and specificity of brush cytology were 78.2% and 90.5%, respectively. The sensitivity of cytology was 77.3% at the ampulla-distal common bile duct (CBD), 92.6% at the mid common hepatic duct (CHD), and 94.7% at the proximal CBD-CHD (p<0.05); these values did not differ with the degree or the length of the obstruction. In the 97 patients who received additional p53 and K-ras staining, the sensitivity of cytology plus p53 was 88.2%, cytology plus K-ras was 84.0%, and cytology plus p53 and K-ras was 88.2%. The sensitivity of cytology plus p53 was higher than that of brush cytology only (95% confidence interval: 83.69-92.78 vs 72.65-83.65) but not that of cytology plus K-ras. CONCLUSIONS: Brush cytology for malignant biliary obstruction has a high diagnostic accuracy. Adding p53 staining can further improve the diagnostic yield, whereas K-ras staining does not.
BACKGROUND/AIMS: Brush cytology during ERCP can provide a pathologic diagnosis in malignant biliary obstruction. K-ras and p53 mutations are commonly found in biliary and pancreatic cancers. We evaluated the diagnostic yield of brush cytology and the changes obtained by adding p53 and K-ras staining. METHODS: One hundred and forty patients with biliary obstruction who underwent ERCP with brush cytology during a 7-year period were included. The sensitivity and specificity of brush cytology only and with the addition of p53 and K-ras staining were obtained. RESULTS:Malignant biliary obstruction was confirmed in 119 patients. The sensitivity and specificity of brush cytology were 78.2% and 90.5%, respectively. The sensitivity of cytology was 77.3% at the ampulla-distal common bile duct (CBD), 92.6% at the mid common hepatic duct (CHD), and 94.7% at the proximal CBD-CHD (p<0.05); these values did not differ with the degree or the length of the obstruction. In the 97 patients who received additional p53 and K-ras staining, the sensitivity of cytology plus p53 was 88.2%, cytology plus K-ras was 84.0%, and cytology plus p53 and K-ras was 88.2%. The sensitivity of cytology plus p53 was higher than that of brush cytology only (95% confidence interval: 83.69-92.78 vs 72.65-83.65) but not that of cytology plus K-ras. CONCLUSIONS: Brush cytology for malignant biliary obstruction has a high diagnostic accuracy. Adding p53 staining can further improve the diagnostic yield, whereas K-ras staining does not.
Authors: Evan L Fogel; Mario deBellis; Lee McHenry; James L Watkins; John Chappo; Harvey Cramer; Suzette Schmidt; Laura Lazzell-Pannell; Stuart Sherman; Glen A Lehman Journal: Gastrointest Endosc Date: 2006-01 Impact factor: 9.427
Authors: Nasim Mahmoudi; Robert Enns; Jack Amar; Jaber AlAli; Eric Lam; Jennifer Telford Journal: World J Gastroenterol Date: 2008-01-28 Impact factor: 5.742
Authors: J L Van Laethem; V Bourgeois; J Parma; M Delhaye; P Cochaux; T Velu; J Devière; M Cremer Journal: Gastrointest Endosc Date: 1998-06 Impact factor: 9.427
Authors: R H Bardales; M W Stanley; D D Simpson; S J Baker; C T Steele; R F Schaefer; C N Powers Journal: Am J Clin Pathol Date: 1998-05 Impact factor: 2.493
Authors: M Tascilar; P D Sturm; E Caspers; M Smit; M M Polak; K Huibregtse; L A Noorduyn; G J Offerhaus Journal: Cancer Date: 1999-10-25 Impact factor: 6.860
Authors: P D Sturm; E A Rauws; R H Hruban; E Caspers; T B Ramsoekh; K Huibregtse; L A Noorduyn; G J Offerhaus Journal: Clin Cancer Res Date: 1999-03 Impact factor: 12.531